Treatment of menstrual migraine: Utility of control of related mood disturbances

Andrea Negro, Flavia Napoletano, Luana Lionetto, Francesco Marsibilio, Gabriele Sani, Paolo Girardi, Paolo Martelletti

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.

Original languageEnglish
Pages (from-to)493-502
Number of pages10
JournalExpert Review of Neurotherapeutics
Volume14
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Migraine Disorders
Mood Disorders
Therapeutics
Population
Hormones
Depression
Recurrence

Keywords

  • affective disorders
  • comorbidity
  • estrogens
  • menstrual migraine
  • non-steroidal anti-inflammatory drugs
  • premenstrual syndrome
  • triptans

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Negro, A., Napoletano, F., Lionetto, L., Marsibilio, F., Sani, G., Girardi, P., & Martelletti, P. (2014). Treatment of menstrual migraine: Utility of control of related mood disturbances. Expert Review of Neurotherapeutics, 14(5), 493-502. https://doi.org/10.1586/14737175.2014.906304

Treatment of menstrual migraine : Utility of control of related mood disturbances. / Negro, Andrea; Napoletano, Flavia; Lionetto, Luana; Marsibilio, Francesco; Sani, Gabriele; Girardi, Paolo; Martelletti, Paolo.

In: Expert Review of Neurotherapeutics, Vol. 14, No. 5, 2014, p. 493-502.

Research output: Contribution to journalArticle

Negro, A, Napoletano, F, Lionetto, L, Marsibilio, F, Sani, G, Girardi, P & Martelletti, P 2014, 'Treatment of menstrual migraine: Utility of control of related mood disturbances', Expert Review of Neurotherapeutics, vol. 14, no. 5, pp. 493-502. https://doi.org/10.1586/14737175.2014.906304
Negro, Andrea ; Napoletano, Flavia ; Lionetto, Luana ; Marsibilio, Francesco ; Sani, Gabriele ; Girardi, Paolo ; Martelletti, Paolo. / Treatment of menstrual migraine : Utility of control of related mood disturbances. In: Expert Review of Neurotherapeutics. 2014 ; Vol. 14, No. 5. pp. 493-502.
@article{2776682785f84014982bb0d58f8b816c,
title = "Treatment of menstrual migraine: Utility of control of related mood disturbances",
abstract = "Menstrual migraine (MM) has a prevalence in the general population of approximately 7{\%}, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.",
keywords = "affective disorders, comorbidity, estrogens, menstrual migraine, non-steroidal anti-inflammatory drugs, premenstrual syndrome, triptans",
author = "Andrea Negro and Flavia Napoletano and Luana Lionetto and Francesco Marsibilio and Gabriele Sani and Paolo Girardi and Paolo Martelletti",
year = "2014",
doi = "10.1586/14737175.2014.906304",
language = "English",
volume = "14",
pages = "493--502",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Treatment of menstrual migraine

T2 - Utility of control of related mood disturbances

AU - Negro, Andrea

AU - Napoletano, Flavia

AU - Lionetto, Luana

AU - Marsibilio, Francesco

AU - Sani, Gabriele

AU - Girardi, Paolo

AU - Martelletti, Paolo

PY - 2014

Y1 - 2014

N2 - Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.

AB - Menstrual migraine (MM) has a prevalence in the general population of approximately 7%, although it seems to be much higher within the population of females with migraine. Episodes of MM have been reported to be longer, more intense, more disabling, less responsive to acute therapy and more prone to recurrence than those of other types of migraine. MM is demonstrated to have a bi-directional link to affective illnesses such as premenstrual dysphoric disorder and depression. There is clinical and pathophysiological evidence suggesting that the relationship between MM and affective disorders could be linked to ovarian hormones. The aim of this review is to analyze treatment strategies in patients with co-existent MM and affective disorders.

KW - affective disorders

KW - comorbidity

KW - estrogens

KW - menstrual migraine

KW - non-steroidal anti-inflammatory drugs

KW - premenstrual syndrome

KW - triptans

UR - http://www.scopus.com/inward/record.url?scp=84899053088&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899053088&partnerID=8YFLogxK

U2 - 10.1586/14737175.2014.906304

DO - 10.1586/14737175.2014.906304

M3 - Article

C2 - 24701991

AN - SCOPUS:84899053088

VL - 14

SP - 493

EP - 502

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 5

ER -